Back to search
High Risk of Stroke
Clinical trial pipeline · Data from ClinicalTrials.gov
See which High Risk of Stroke trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which High Risk of Stroke trials you may qualify forTest the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurolo…
Intracranial atherosclerotic disease is the most common cause of ischemic stroke that is directly attributed to the progression or rupture of intracranial high-…
To clarify the clinical efficacy of high-frequency rTMS on patients with post-stroke cognitive impairment, fNIRS and EEG techniques were used to observe the cha…
The purpose of this research study is to explore whether genetic testing can offer a personalized and timely approach to assist physicians in making more inform…
Stroke survivors with lower limb disability can improve their walking speed with high-intensity interval training (HIIT) rehabilitation therapy. However, some i…
The aim of this study is to investigate the effect of post-stroke sarcopenia on prognosis and clinical outcomes in patients with ischemic stroke and to compare…
The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.
The purpose of this study is to examine whether 3 weeks of intensive language therapy provided in clinical in- and outpatient settings is effective in improving…
The Oris trial aims to evaluate whether the use of Ongericimab injection in patients with atherosclerotic ischemic cerebrovascular disease within 3 months of on…